Showing results (31-40 of 56) with videos related to
Sort By:
Pageof 6
American Journal of Human Genetics|April 1, 1996
Genetic and biochemical impairment of mitochondrial complex I activity in a family with Leber hereditary optic neuropathy and hereditary spastic dystoniaD D De Vries, L N Went, G W Bruyn, et al.Journal of Medical Genetics|June 30, 2000
A consanguineous family with Hirschsprung disease, microcephaly, and mental retardation (Goldberg-Shprintzen syndrome)A S Brooks, M H Breuning, J Osinga, et al.Oncogene|November 2, 1995
The physical map of the human RET proto-oncogeneB Pasini, R M Hofstra, L Yin, et al.Genes, Chromosomes & Cancer|April 29, 1998
Investigation of the genes for RET and its ligand complex, GDNF/GFR alpha-I, in small cell lung carcinomaL M Mulligan, T Timmer, S M Ivanchuk, et al.Genes, Chromosomes & Cancer|April 1, 1997
MSH2 and MLH1 mutations in sporadic replication error-positive colorectal carcinoma as assessed by two-dimensional DNA electrophoresisY Wu, M Nyström-Lahti, J Osinga, et al.Gut|April 17, 2001
Analysis of the RET, GDNF, EDN3, and EDNRB genes in patients with intestinal neuronal dysplasia and Hirschsprung diseaseR Gath, A Goessling, K M Keller, et al.Human Genetics|March 1, 1996
No mutations found by RET mutation scanning in sporadic and hereditary neuroblastomaR M Hofstra, N C Cheng, C Hansen, et al.Nature|January 27, 1994
A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinomaR M Hofstra, R M Landsvater, I Ceccherini, et al.Cancer Research|November 1, 1996
Somatic mutations of the RET proto-oncogene are not required for tumor development in multiple endocrine neoplasia type 2 (MEN 2) gene carriersR M Landsvater, M J de Wit, R A Zewald, et al.Human Pathology|January 11, 2001
Adrenocortical adenocarcinoma in an MSH2 carrier: coincidence or causal relation?M J Berends, A Cats, H Hollema, et al.Pageof 6